Endogenous ouabain in renal Na+handling and related diseases

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 12, 2010, Pages 1214-1218

  Manunta, Paolo ^a   Messaggio, Elisabetta ^a   Casamassima, Nunzia ^a   Gatti, Guido ^a   Delli Carpini, Simona ^a   Zagato, Laura ^a   Hamlyn, John M ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Kidney; Na pump; Salt

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADRENALIN; ANGIOTENSIN II; CORTICOTROPIN; OUABAIN; SODIUM ION;

BIOSYNTHESIS; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HYPERTENSION; KIDNEY; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER;

STROPHANTHUS GRATUS;

EID: 78049307475     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.03.001     Document Type: Review

References (66)

1. Eaton S.B., Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N. Engl. J. Med. 1985, 312:283-289.
2. Adrogue H.J., Madias N.E. Sodium and potassium in the pathogenesis of hypertension. N. Engl. J. Med. 2007, 356:1966-1978.
3. Guyton A.C., Coleman T.G., Cowley A.W., Liard J.F., Norman R.A., Manning R.D. Systems analysis of arterial pressure regulation and hypertension. Ann. Biomed. Eng. 1972, 1:254-281.
4. Manunta P., Hamilton B.P., Hamlyn J.M. Structure-activity relationships for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring. Hypertension 2001, 37:472-477.
5. Schneider R., Wray V., Nimtz M., Lehmann W.D., Kirch U., Antolovic R., Schoner W. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J. Biol. Chem. 1998, 273:784-792.
6. el-Masri M.A., Clark B.J., Qazzaz H.M., Valdes R. Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors. Clin. Chem. 2002, 48:1720-1730.
7. Kawamura A., Guo J., Itagaki Y., Bell C., Wang Y., Haupert G.T., Magil S., Gallagher R.T., Berova N., Nakanishi K. On the structure of endogenous ouabain. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6654-6659.
8. Tymiak A.A., Norman J.A., Bolgar M., Di Donato G.C., Lee H., Parker W.L., Lo L.C., Berova N., Nakanishi K., Haber E., Haupert G.T. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:8189-8193.
9. Komiyama Y., Nishimura N., Munakata M., Mori T., Okuda K., Nishino N., Hirose S., Kosaka C., Masuda M., Takahashi H. Identification of endogenous ouabain in culture supernatant of PC12 cells. J. Hypertens. 2001, 19:229-236.
10. Ferrandi M., Minotti E., Salardi S., Florio M., Bianchi G., Ferrari P. Characteristics of a ouabain-like factor from Milan hypertensive rats. J. Cardiovasc. Pharmacol. 1993, 22:S75-S78.
11. Tamura M., Harris T.M., Phillips D., Blair I.A., Wang Y.F., Hellerqvist C.G., Lam S.K., Inagami T. Identification of two cardiac glycosides as Na(+)-pump inhibitors in rat urine and diet. J. Biol. Chem. 1994, 269:11972-11979.
12. Vakkuri O., Arnason S.S., Pouta A., Vuolteenaho O., Leppäluoto J. Radioimmunoassay of plasma ouabain in healthy and pregnant individuals. J. Endocrinol. 2000, 165:669-677.
13. Di Bartolo V., Balzan S., Pieraccini L., Ghione S., Pegoraro S., Biver P., Revoltella R., Montali U. Evidence for an endogenous ouabain-like immunoreactive factor in human newborn plasma coeluted with ouabain on HPLC. Life Sci. 1995, 57:1417-1425.
14. Manunta P., Ferrandi M., Bianchi G., Hamlyn J.M. Endogenous ouabain in cardiovascular function and disease. J. Hypertens. 2009, 27:9-18.
15. Hamlyn J.M., Blaustein M.P., Bova S., DuCharme D.W., Mandel F., Mathews W.R., Ludens J.H. Identification and characterization of a ouabain-like compound from human plasma. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:6259-6263.
16. Schneider R., Wray V., Nimtz M., Lehmann W.D., Kirch U., Antolovic R., Schoner W. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J. Biol. Chem. 1998, 273:784-792.
17. Komiyama Y., Nishimura N., Dong X.H., Hirose S., Kosaka C., Masaki H., Masuda M., Takahashi H. Liquid chromatography mass spectrometric analysis of ouabain-like factor in biological fluid. Hypertens. Res. 2000, 23:S21-S27.
18. Ludens J.H., Clark M.A., Robinson F.G., DuCharme D.W. Rat adrenal cortex is a source of a circulating ouabainlike compound. Hypertension 1992, 19:721-724.
19. Rossi G., Manunta P., Hamlyn J.M., Pavan E., De Toni R., Semplicini A., Pessina A.C. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. J. Hypertens. 1995, 13:1181-1191.
20. Boulanger B.R., Lilly M.P., Hamlyn J.M., Laredo J., Shurtleff D., Gann D.S. Ouabain is secreted by the adrenal gland in awake dogs. Am. J. Physiol. 1993, 264:E413-E419.
21. Manunta P., Evans G., Hamilton B.P., Gann D., Resau J., Hamlyn J.M. A new syndrome with elevated plasma ouabain and hypertension secondary to an adrenocortical tumor. J. Hypertens. 1992, 10:S27.
22. Masugi F., Ogihara T., Hasegawa T., Sakaguchi K., Kumahara Y. Normalization of high plasma level of ouabain-like immunoreactivity in primary aldosteronism after removal of adenoma. J. Hum. Hypertens. 1988, 2:17-20.
23. Laredo J., Hamilton B.P., Hamlyn J.M. Ouabain is secreted by bovine adrenocortical cells. Endocrinology 1994, 135:794-797.
24. Sophocleous A., Elmatzoglou I., Souvatzoglou A. Circulating endogenous digitalis-like factor(s) (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent. J. Endocrinol. Investig. 2003, 26:668-674.
25. Manunta P., Ferrandi M., Messaggio E., Ferrari P. A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducing. Cardiovasc. Hematol. Agents Med. Chem. 2006, 4:61-66.
26. Murrell J.R., Randall J.D., Rosoff J., Zhao J.L., Jensen R.V., Gullans S.R., Haupert G.T. Endogenous ouabain: upregulation of steroidogenic genes in hypertensive hypothalamus but not adrenal. Circulation 2005, 112:1301-1308.
27. Perrin A., Brasmes B., Chambaz E.M., Defaye G. Bovine adrenocortical cells in culture synthesize an ouabain-like compound. Mol. Cell. Endocrinol. 1997, 126:7-15.
28. Lu Z., Shah J., Hamilton B., Hamlyn J. Biosynthesis of endogenous ouabain from pregnenolone and progesterone in bovine adrenal cortical cells. Hypertension 1998, 32:131.
29. Lichtstein D., Steinitz M., Gati I., Samuelov S., Deutsch J., Orly J. Biosynthesis of digitalis-like compounds in rat adrenal cells: hydroxycholesterol as possible precursor. Life Sci. 1998, 62:2109-2126.
30. Stella P., Manunta P., Mallamaci F., Melandri M., Spotti D., Tripepi G., Hamlyn J.M., Malatino L.S., Bianchi G., Zoccali C. Endogenous ouabain and cardiomyopathy in dialysis patients. J. Intern. Med. 2008, 263:274-280.
31. Mikkaichi T., Suzuki T., Onogawa T., Tanemoto M., Mizutamari H., Okada M., Chaki T., Masuda S., Tokui T., Eto N., Abe M., Satoh F., Unno M., Hishinuma T., Inui K., Ito S., Goto J., Abe T. Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3569-3574.
32. Inui K.L., Masuda S., Saito H. Cellular and molecular aspects of drug transport in the kidney. Kidney Int. 2000, 58:944-958.
33. Tripodi G., Citterio L., Kouznetsova T., Lanzani C., Florio M., Modica R., Messaggio E., Hamlyn J.M., Zagato L., Bianchi G., Staessen J.A., Manunta P. Steroid biosynthesis and renal excretion in human essential hypertension: association with blood pressure and endogenous ouabain. Am. J. Hypertens. 2009, 22:357-363.
34. O'Shaughnessy K.M., Karet F.E. Salt handling and hypertension. J. Clin. Investig. 2004, 113:1075-1081.
35. He F.J., Markandu N.M., Sagnella G.A., de Wardener H.E., MacGregor G.A. Plasma sodium. Ignored and underestimated. Hypertension 2005, 45:98-102.
36. Wang J.G., Staessen J.A., Messaggio E., Nawrot T., Fagard R., Hamlyn J.M., Bianchi G., Manunta P. Salt, endogenous ouabain and blood pressure interactions in the general population. J. Hypertens. 2003, 21:1475-1481.
37. Manunta P., Hamilton B.P., Hamlyn J.M. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R553-R559.
38. Manunta P., Stella P., Rivera R., Ciurlino D., Cusi D., Ferrandi M., Hamlyn J.M., Bianchi G. Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 1999, 34:450-456.
39. Manunta P., Messaggio E., Ballabeni C., Sciarrone M.T., Lanzani C., Ferrandi M., Hanlyn J.M., Cusi D., Galletti F., Bianchi G. Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension. Hypertension 2001, 38:198-203. Salt Sensitivity Study Group of the Italian Society of Hypertension.
40. Pierdomenico S.D., Bucci A., Manunta P., Rivera R., Ferrandi M., Hamlyn J.M., Lapenna D., Cuccurullo F., Mezzetti A. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. Am. J. Hypertens. 2001, 14:44-50.
41. Manunta P., Maillard M., Tantardini C., Simonini M., Lanzani C., Citterio L., Stella P., Casamassima N., Burnier M., Hamlyn J.M., Bianchi G. Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension. J. Hypertens. 2008, 26:914-920.
42. He F.J., Markandu N.M., Sagnella G.A., de Wardener H.E., MacGregor G.A. Plasma sodium. Ignored and underestimated. Hypertension 2005, 45:98-102.
43. Bosher S.K., Warren R.L. Observations on the electrochemistry of the cochlear endolymph of the rat: a quantitative study of its electrical potential and ionic composition as determined by means of flame spectrophotometry. Proc. R. Soc. Lond. B Biol. Sci. 1968, 171:227-247.
44. Salt A.N., Melichar I., Thalmann R. Mechanisms of endocochlear potential generation by stria vascularis. Laryngoscope 1987, 97:984-991.
45. Yamane H., Nakai Y. Immunohistochemical localization of the Na+-K+ATPase in the endolymphatic sac. Adv. Otorhinolaryngol. 1988, 42:123-128.
46. Pitovski D.Z., Kerr T.P. Sodium- and potassium-activated ATPase in the mammalian vestibular system. Hear. Res. 2002, 171:51-65.
47. Konishi T., Mendelsohn M. Effect of ouabain on cochlear potentials and endolymph composition in guinea pigs. Acta Otolaryngol. (Stockh) 1970, 69:192-199.
48. Bosher S.K. The effect of inhibition of the strial Na+-K+ activated ATPase by perilymphatic ouabain in the guinea pig. Acta Otolaryngol. (Stockh) 1980, 90:219-229.
49. Hamada M., Kimura R.S. Morphological changes induced by administration of a Na+-K+ATPase inhibitor in normal and hydropic inner ears of the guinea pig. Acta Otolaryngol. (Stockh) 1999, 119:778-786.
50. Teggi R., Lanzani C., Zagato L., Delli Carpini S., Messaggio E., Casamassima N., Lanzani C., Manunta P., Bussi M. Endogenous ouabain in Ménière's disease. Otol. Neurotol. 2010, 31:153-156.
51. Teggi R., Lanzani C., Zagato L., Delli Carpini S., Manunta P., Bianchi G., Bussi M. Gly460Trp alpha-adducin mutation as a possible mechanism leading to endolymphatic hydrops in Ménière's syndrome. Otol. Neurotol. 2008, 29:824-828.
52. Ferrandi M., Molinari I., Barassi P., Minotti E., Bianchi G., Ferrari P. Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST2238. J. Biol. Chem. 2004, 279:33306-33314.
53. Manunta P., Iacoviello M., Forleo C., Messaggio E., Hamlyn J.M., Lucarelli K., Guida P., Romito R., De Tommasi E., Bianchi G., Rizzon P., Pitzalis M.V. High circulating levels of endogenous ouabain in the offspring of hypertensive and normotensive individuals. J. Hypertens. 2005, 23:1677-1681.
54. Kuznetsova T., Manunta P., Casamassima N., Messaggio E., Jin Y., Thijs L., Richart T., Fagard R.H., Bianchi G., Staessen J.A. Left ventricular geometry and endogenous ouabain in a Flemish population. J. Hypertens. 2009, 27:1884-1891.
55. Pitzalis M.V., Hamlyn J.M., Messaggio E., Iacoviello M., Forleo C., Romito R., De Tommasi E., Rizzon P., Bianchi G., Manunta P. Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy. Eur. J. Heart Fail. 2006, 8:179-186.
56. Navaneethan S.D., Bonifati C., Schena F.P., Strippoli G.F. Evidence for optimal targets in chronic kidney disease. J. Nephrol. 2006, 19:640-647.
57. Bortotolotto L.A., Costa-Hong V., Jorgetti V., Consolim-Colombo F., Rosa K., Silva B.C., Krieger E.M., De Lima J.J. Vascular changes in chronic renal disease patients with secondary hyperparathyroidism. J. Nephrol. 2007, 20:66-72.
58. Zoccali C., Mallamaci F., Tripepi G., Parlongo S., Cutrupi S., Benedetto F.A., Cataliotti A., Malatino L.S. Norepinephrine and concentric hypertrophy in patients with end-stage renal disease. Hypertension 2002, 40:41-46. CREED investigators.
59. Kometiani P., Li J., Gnudi L., Kahn B.B., Askari A., Xie Z. Multiple signal transduction pathways link Na+/ K+-ATPase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases. J. Biol. Chem. 1998, 273:15249-15256.
60. Trevisi L., Visentin B., Cusinato F., Pighin I., Luciani S. Antiapoptotic effect of ouabain on human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 2004, 321:716-721.
61. Blaustein M.P., Zhang J., Chen L., Song H., Raina H., Kinsey S.P., Izuka M., Iwamoto T., Kotlikoff M.I., Lingrel J.B., Philipson K.D., Wier W.G., Hamlyn J.M. The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension 2009, 53:291-298.
62. Zhang J., Lee M.Y., Cavalli M., Chen L., Berra-Romani R., Balke C.W., Bianchi G., Ferrari P., Hamlyn J.M., Iwamoto T., Lingrel J.B., Matteson D.R., Wier W.G., Blaustein M.P. Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice. J. Physiol. 2005, 569:243-256.
63. Dostanic I., Paul R.J., Lorenz J.N., Theriault S., Van Huysse J.W., Lingrel J.B. The alpha2-isoform of Na/K-ATPasemediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H477-H485.
64. Zhang J., Hamlyn J.M., Karashima E., Raina H., Mauban J.R., Izuka M., Berra-Romani R., Zulian A., Wier W.G., Blaustein M.P. Low-dose ouabain constricts small arteries from ouabain-hypertensive rats: implications for sustained elevation of vascular resistance. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1140-H1150.
65. Li Z., Xie Z. The Na/K-ATPase/Src complex and cardiotonic steroid activated protein kinase cascades. Pflugers Arch. 2009, 457:635-644.
66. Schoner W., Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am. J. Physiol. Cell Physiol. 2007, 293:C509-C536.